Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4757013
Max Phase: Preclinical
Molecular Formula: C28H30F3N9
Molecular Weight: 549.61
Molecule Type: Unknown
Associated Items:
ID: ALA4757013
Max Phase: Preclinical
Molecular Formula: C28H30F3N9
Molecular Weight: 549.61
Molecule Type: Unknown
Associated Items:
Canonical SMILES: Cn1c(-c2ccc(C3=CCN(C(=N)N)CC3)cc2)nnc1-c1ccc(C2=CCN(C(=N)N)CC2)c(C(F)(F)F)c1
Standard InChI: InChI=1S/C28H30F3N9/c1-38-24(20-4-2-17(3-5-20)18-8-12-39(13-9-18)26(32)33)36-37-25(38)21-6-7-22(23(16-21)28(29,30)31)19-10-14-40(15-11-19)27(34)35/h2-8,10,16H,9,11-15H2,1H3,(H3,32,33)(H3,34,35)
Standard InChI Key: XAXXYLYTERUIBV-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 549.61 | Molecular Weight (Monoisotopic): 549.2576 | AlogP: 4.13 | #Rotatable Bonds: 4 |
Polar Surface Area: 136.93 | Molecular Species: BASE | HBA: 5 | HBD: 4 |
#RO5 Violations: 1 | HBA (Lipinski): 9 | HBD (Lipinski): 6 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: | CX Basic pKa: 12.17 | CX LogP: 3.02 | CX LogD: -1.80 |
Aromatic Rings: 3 | Heavy Atoms: 40 | QED Weighted: 0.29 | Np Likeness Score: -0.70 |
1. Baugh SDP,Chaly A,Weaver DG,Pelletier JC,Thanna S,Freeman KB,Reitz AB,Scott RW. (2021) Highly potent, broadly active antifungal agents for the treatment of invasive fungal infections., 33 [PMID:33316410] [10.1016/j.bmcl.2020.127727] |
Source(1):